FDA Panel Backs Broader Peptide Use in Compounding Pharmacies

An FDA committee endorsed wider use of peptides in lightly regulated compounding pharmacies, which have grown into a multibillion-dollar business. The vote raises concerns about a potential prescribing boom in minimally regulated settings.